Daniels v. Wexford Health Sources, Inc.

CourtDistrict Court, N.D. Illinois
DecidedMarch 9, 2023
Docket1:16-cv-00014
StatusUnknown

This text of Daniels v. Wexford Health Sources, Inc. (Daniels v. Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Daniels v. Wexford Health Sources, Inc., (N.D. Ill. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION JOVAN D. DANIELS, ) ) Plaintiff, ) Case No. 16-cv-00014 ) v. ) Judge Sharon Johnson Coleman ) WEXFORD HEALTH SOURCES, INC., ) et al. ) ) Defendants. )

MEMORANDUM OPINION AND ORDER Plaintiff, Jovan Daniels, brings this action against Wexford Health Sources, Inc. (“Wexford”), La Tanya Williams, P.A. (“PA Williams”), and Ghaliah Obaisi, as Independent Executor of the Estate of Saleh Obaisi, M.D., (“Dr. Obaisi”) (collectively, “defendants”), alleging that defendants violated his rights under the Eighth Amendment by acting with deliberate indifference to his medical needs. For the reasons set forth below, defendants’ motion for summary judgment [184] is granted in part and denied in part. Background The following facts are undisputed unless otherwise noted. Daniels, 44, was formerly incarcerated by the Illinois Department of Corrections (“IDOC”) at Stateville Correctional Center (“Stateville”). Wexford is a private healthcare provider that has contracted with the State of Illinois to provide medical treatment to IDOC inmates, including those incarcerated at Stateville. Dr. Obaisi was employed by Wexford as the medical director at Stateville until his death in 2017. PA Williams has been employed by Wexford as a Physician’s Assistant since 2005. Plaintiff’s Care at Stateville On December 10, 2008, Mr. Williams first presented to PA Williams with complaints of headaches, nausea, dizziness, neck stiffness and tightness, yellow nose discharge, and pain and pressure in his right eye. (Dkt. 186, ¶ 10). PA Williams prescribed plaintiff Periactin, an antihistamine, and Tylenol; she also ordered serum H. Pylori, a blood or stool test. Plaintiff asserts that the medical record from Mr. Daniel’s December 10, 2008 visit include “the first indication of [RA].” (Dkt. 193, ¶ 25). Defendants dispute this characterization. The Court notes that the handwritten medical record in question has two relevant markings: one reads “RF 28 (high),” and the other reads “A. RA.”1 (Dkt 193-4, at 11).

Over the coming years, Mr. Daniels continued to seek attention for related symptoms. On May 20, 2009, he presented to PA Williams with complaints of pain in his left side and sinus problems. (Dkt. 186, ¶ 11). He was prescribed Afrin, a nasal spray; Chlor-Trimeton, an antihistamine; Periactin; and Naprosyn, a non-steroidal anti-inflammatory drug (“NSAID”) for pain and inflammation. PA Williams also ordered a sinus profile. On October 26, 2010, plaintiff presented to PA Williams for complaints of body joint aches. (Dkt 186, ¶ 12). After examination, PA Williams prescribed Tylenol, ordered additional diagnostic testing, and advised plaintiff to apply heat to the affected area and drink more water. On December 14, 2010, plaintiff again presented to PA Williams with complaints of joint pain. (Dkt 186, ¶ 13). PA Williams assessed his nasal complaints as allergic rhinitis. Defendants assert that PA Williams also “noted” that plaintiff’s lab results indicated an elevated rheumatoid factor (“RF”), but plaintiff claims that PA Williams never told him about his elevated RF. (Dkt. 193, at 6). PA Williams prescribed nasal saline for the allergic

rhinitis and Indocin, an NSAID used to treat pain and inflammation, for joint pain. On May 18 and December 12, 2011, plaintiff received x-rays that did not reveal fracture or “arthritic changes.” (Dkt 186, ¶¶ 14, 15).

1 RF may refer here to plaintiff’s rheumatoid factor, a test used to measure risk for diseases including rheumatoid arthritis. RA may refer here to rheumatoid arthritis. Additionally, the precise date on which these markings were made is unclear from the face of the exhibit. Suffice it to say, the content and significance of this particular medical record are a genuine issue of fact. Plaintiff continued to present to PA Williams with joint pain and other symptoms from 2012–2014. On September 4, 2014, plaintiff informed PA Williams that his prescriptions for Naprosyn and Motrin were not effective and he had decided to stop taking the medications. (Dkt 186, ¶ 20). PA Williams again ordered additional testing and assessed Mr. Daniels as having an elevated RF and RA. Per plaintiff, this visit was the first time he was informed of either his elevated RF or RA diagnosis. (Dkt. 193, ¶ 13). On January 20, 2015, PA Williams directed plaintiff to

continue taking Piroxicam, an NSAID he had been prescribed by Dr. Alma Martija. On February 10, 2015, Mr. Daniels again presented to PA Williams with complaints of joint pain. (Dkt. 186, ¶ 23). Plaintiff explained that the Piroxicam was not working. Defendant asserts that plaintiff had ceased taking Piroxicam, but plaintiff disputes this characterization. (Dkt. 193, at 10). On March 27, 2015, plaintiff presented to Dr. Obaisi for complaints of joint pain. (Dkt. 186, ¶ 24). Dr. Obaisi prescribed Bentyl, for plaintiff’s irritable bowel syndrome (“IBS”); Mobic, an NSAID; and Sulfalazine, a disease-modifying anti-rhematic drug (“DMARD”) used to treat symptoms of rheumatoid arthritis. Plaintiff saw Dr. Obaisi again on May 21, 2015, and explained that the pain medication was not working and he wanted to see a rheumatologist; Dr. Obaisi then made a referral for plaintiff to be seen by a rheumatologist. (Dkt. 186, ¶ 26). Care after Stateville On June 25, 2015, plaintiff was transferred to Menard Correctional Center (“Menard”).

There, he began visiting a neurology and arthritis clinic. His specialist, Dr. Amar Sawar, prescribed Methodextrate, an immunosuppressive drug used to treat RA, which plaintiff took for approximately two to three months with little effect. (Dkt. 186, ¶ 29). Plaintiff left IDOC on parole in July 2019. Plaintiff has attended a number of medical appointments since his incarceration ended. He has not been treated for RA, nor have his care providers indicated that he suffers from joint inflammation or other symptoms of RA. Wexford Policy Certain Wexford policies and procedures are also relevant to this action. Wexford’s employee handbook directs staff not to explain to inmates symptoms they would expect to see to confirm a diagnosis. (Dkt. 193, ¶ 6). Legal Standard Summary judgment is proper when “the pleadings, the discovery and disclosure materials on

file, and any affidavits show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(c); Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S. Ct. 2548, 91 L. Ed. 2d 265 (1986). In determining whether a genuine issue of material fact exists, this Court must view the evidence and draw all reasonable inferences in favor of the party opposing the motion. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255, 106 S. Ct. 2505, 91 L. Ed. 2d 202 (1986). However, “[m]erely alleging a factual dispute cannot defeat the summary judgment motion.” Samuels v. Wilder, 871 F.2d 1346, 1349 (7th Cir. 1989). “The mere existence of a scintilla of evidence in support of the [non-movant's] position will be insufficient; there must be evidence on which the jury could reasonably find for the [non-movant].” Anderson, 477 U.S. at 252. Discussion The Court finds that there is a genuine issue of material fact as to whether the individual defendants were deliberately indifferent to plaintiff’s serious medical condition, and thus denies

defendants’ motion for summary judgment with respect to defendants PA Williams and Dr. Obaisi.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
McGowan v. Hulick
612 F.3d 636 (Seventh Circuit, 2010)
Roe v. Elyea
631 F.3d 843 (Seventh Circuit, 2011)
Howard B. Samuels v. Jack Wilder
871 F.2d 1346 (Seventh Circuit, 1989)
Arnett v. Webster
658 F.3d 742 (Seventh Circuit, 2011)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
Anthony Maniscalco v. Jay Simon
712 F.3d 1139 (Seventh Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Minix v. Canarecci
597 F.3d 824 (Seventh Circuit, 2010)
Hayes v. Snyder
546 F.3d 516 (Seventh Circuit, 2008)
Patrick Hahn v. Daniel Walsh
762 F.3d 617 (Seventh Circuit, 2014)
Christopher Pyles v. Magid Fahim
771 F.3d 403 (Seventh Circuit, 2014)
Miguel Perez v. James Fenoglio
792 F.3d 768 (Seventh Circuit, 2015)
Wilson v. Adams
901 F.3d 816 (Seventh Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Daniels v. Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/daniels-v-wexford-health-sources-inc-ilnd-2023.